Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein

Published:2010-09 Issue:3 Volume:18 Page:258-267
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Yang Qingkai,Deng Xianming,Lu Bingwen,Cameron Michael,Fearns Colleen,Patricelli Matthew P.,Yates John R.,Gray Nathanael S.,Lee Jiing-Dwan

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference43 articles.

1. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase;Abe;J. Biol. Chem.,1996

2. The promise of retinoids to fight against cancer;Altucci;Nat. Rev. Cancer,2001

3. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies;Bernardi;Nat. Rev. Mol. Cell Biol.,2007

4. PML regulates p53 stability by sequestering Mdm2 to the nucleolus;Bernardi;Nat. Cell Biol.,2004

5. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR;Bernardi;Nature,2006

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer;EMBO Molecular Medicine;2024-09-13

3. Latent-Transforming Growth Factor β-Binding Protein 1/Transforming Growth Factor β1 Complex Drives Antitumoral Effects upon ERK5 Targeting in Melanoma;The American Journal of Pathology;2024-08

4. Statins enhance extracellular release of hepatitis C virus particles through ERK5 activation;Microbiology and Immunology;2024-07-29

5. The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib;FEBS Letters;2024-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3